Market Highlights
Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA...
The report "Global Carcinoembryonic Antigen Market" provides a powerful basis for assessing the market and identifying with it other basic technicalities. The exam reveals the Carcinoembryonic Antigen market complete evaluation and true components. The study shows a simple overview of the market, which includes apps, blueprints, the structure of the supply chain, and definitions. It also...
Global Carcinoembryonic Antigen Market – Overview
Carcinoembryonic Antigen or CEA is a kind of glycoprotein produced by cells of the gastrointestinal tract during foetal development which is involved in cell adhesion. Its level is low in healthy adults. However, high levels of CEA are marked in cancerous conditions. The normal range for CEA in an adult who is non-smoker is estimated to be...
Global Carcinoembryonic Antigen Market – Overview
Carcinoembryonic Antigen or CEA is a kind of glycoprotein produced by cells of the gastrointestinal tract during foetal development which is involved in cell adhesion. Its level is low in healthy adults. However, high levels of CEA are marked in cancerous conditions. The normal range for CEA in an adult who is non-smoker is estimated to be...